Evogene EVGN Cash Flow Statement (2012-2026)

NASDAQ EVGN
$0.44 +0.04 (+9.70%)
At close: Oct 1, 2026 · 4:00 PM EDT
Reported Financials

Evogene Quarterly Cash Flow Statement

Periods 55 quarters
Latest Jun 2026

Evogene reported cash from operations of -$1.97M and free cash flow of -$1.97M for the quarter ended Jun 2026, up 14.2% year over year. This cash flow statement covers 55 quarters of results from Dec 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-8.34M-8.08M-9.11M-9.75M-7.16M-3.82M-6.98M-7.78M-3.86M-7.34M-3.85M-5.99M-8.22M-0.01M-2.99M-4.68M5.20M-5.35M-5.90M-1.77M
Depreciation and Depletion
0.21M0.44M0.28M0.26M
Share-based Compensation
0.78M0.74M0.41M0.42M0.07M0.29M0.42M0.80M0.55M0.11M0.54M0.31M0.36M0.26M0.24M0.22M0.03M0.15M-0.01M0.09M
Deferred Taxes
-0.09M0.09M
Cash from Discontinued Operations
-0.03M-1.03M-0.96M-1.15M-0.23M-0.14M0.04M-0.05M
Asset Writedowns and Impairment
0.12M
Cash from Restructuring
2.10M
Non-cash Items
1.99M-4.49M-0.78M0.82M
Change in Interest Receivables
0.01M-0.00M0.01M
Cash from Operations
-5.81M-8.08M-7.71M-6.66M-7.06M-2.26M-6.24M-5.09M-4.32M-5.92M-4.11M-5.46M-4.93M-4.56M-5.18M-2.30M-2.69M-2.95M-1.97M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
0.23M0.23M0.34M0.24M0.24M0.24M0.24M0.24M0.24M0.24M0.24M0.24M0.24M0.24M0.24M
Amortization of Deferred Charges
0.14M0.33M0.33M0.33M0.33M0.33M1.72M
Depreciation & Amortization (CF)Depreciation & Amortization
0.31M0.32M0.35M0.37M0.40M0.40M0.40M0.41M0.42M0.42M0.43M0.33M0.38M0.35M0.31M0.24M0.28M0.26M0.20M0.15M
Change in Working Capital
Change in Receivables
0.06M-0.13M0.12M0.06M-0.34M0.10M0.10M0.07M-1.17M0.99M-0.18M0.30M-1.35M0.60M-1.53M1.47M0.73M-0.00M0.03M-0.10M
Change in Inventory
-0.09M-0.08M0.01M-0.00M-0.40M-0.03M0.34M0.14M0.04M-0.64M-0.16M-0.67M-0.38M-0.45M-0.15M-0.14M-0.28M0.04M0.08M
Change in Account Payables
0.63M-0.36M-0.17M-0.01M-0.43M0.13M0.12M-0.10M0.15M0.56M-0.69M-0.08M0.25M-0.17M-0.31M0.07M-0.08M0.19M-0.12M0.04M
Change in Accured Expenses
0.14M0.30M-0.01M-0.37M-0.06M-0.44M0.06M0.12M-0.10M0.48M-0.10M-0.01M-0.03M-0.40M-0.23M0.06M-0.44M-0.19M0.06M-0.01M
Change in Taxes
-0.01M0.01M-0.00M-0.03M-0.01M-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.01M0.01M
Other Working Capital Changes
-0.03M0.17M-0.06M-0.10M0.34M-0.34M0.01M-0.08M0.26M-0.48M-0.07M-0.03M0.01M-0.46M-0.20M-0.01M-0.01M-0.00M
Investing Activities
Capital Expenditures
-0.18M-0.26M-0.44M-0.30M-0.23M-0.20M-0.03M-0.12M-0.22M-0.09M-0.14M0.01M0.03M-0.32M-0.12M-0.00M0.12M-0.01M-0.00M-0.01M
Sales of Property, Plant and Equipment
0.61M-1.02M9.42M2.73M0.20M0.00M0.03M6.29M-0.05M0.05M0.52M0.01M-0.00M0.00M0.00M-0.00M0.01M-0.03M0.02M0.01M
Change in Acquisitions & Divestments
-1.60M0.60M3.00M-3.00M-13.56M3.86M-0.50M-5.44M3.24M2.10M7.77M-2.33M-1.00M7.40M-4.53M2.93M
Cash from Investing Activities
-1.58M2.01M11.98M1.76M-0.02M-0.45M0.30M-7.90M3.64M-0.59M-4.36M3.21M2.02M1.31M-2.44M-0.99M2.80M-4.49M1.60M
Financing Activities
Other financing activities
-0.01M
Debt Issuance and Repayment
Long-Term Debt Issuances
10.00M
Long-Term Debt Repayments
-0.23M-0.15M-0.12M
Change in Capital Stock
Net Preferred Shares Issued and Repurchased
4.28M
Net Equity Issued and Repurchased
0.02M0.01M0.01M0.02M0.27M0.07M8.07M0.04M0.00M0.08M0.04M2.17M0.23M0.16M
Dividend Payments
Dividends Paid - Common
4.25M
Dividends Paid - Common and Prefferd
4.25M
Misc.
Cash from Financing Activities
1.95M-0.10M-0.10M-0.37M10.17M-0.36M0.05M10.45M7.80M-0.15M-0.37M0.00M5.38M-0.21M-0.16M0.00M-10.34M-0.26M2.99M
Change in Cash
-5.12M-5.31M-7.15M2.99M-2.88M-2.77M7.10M-6.56M-2.43M1.83M3.98M-7.81M0.90M-2.77M7.33M-4.45M
Beginning Cash Balance
42.76M37.63M36.01M28.87M23.00M20.23M27.33M11.91M9.48M11.32M15.30M7.50M8.33M5.63M12.96M
Free Cash Flow
-5.63M-7.82M-7.26M-6.35M-6.83M-2.06M-6.22M-4.97M-4.10M-5.84M-3.97M-5.47M-4.96M-4.24M-5.06M-2.30M-0.12M-2.68M-2.95M-1.97M
Net Cash Flow
-5.44M-6.18M4.17M-5.27M3.09M-3.06M-5.89M-2.54M7.13M-6.66M-8.84M-2.24M2.47M-3.46M-7.79M-3.29M-10.34M-0.14M-4.45M-0.37M

Evogene Cash Flow Statement API

Pull Evogene's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=EVGN&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY